手机在线买球app is committed to protecting our communities from the spread of COVID-19. Find the latest information on COVID-19, including vaccines, testing, and treatment.
手机在线买球app clinical leaders provide an update on the impact of the Omicron variant in our communities. They also share more information about Evusheld — the first-ever monoclonal antibody authorized by the U.S. Food and Drug Administration (FDA) for the prevention of COVID-19 prior to an exposure — which we give to patients with immune-compromising conditions.找到更多的最新新闻
美国.S. Food and Drug Administration (FDA) has authorized monoclonal antibodies as a COVID-19 treatment. The treatment has shown promise in reducing the risk of severe illness, hospitalization, and death. 手机在线买球app is a national leader in providing monoclonal antibodies as a treatment for COVID-19. Learn more about monoclonal antibodies and who is eligible for the treatment.了解更多关于这种治疗方法
COVID-19 is a respiratory disease caused by novel coronavirus SARS-CoV-2. It can cause symptoms ranging from mild to severe, including hospitalization and death. Some people may experience no symptoms at all. 了解更多关于COVID-19的信息.COVID-19常见问题
Receive health tips, COVID-19 information, and more to your inbox.